SCHEMBL8852945

SCHEMBL8852945

COC1=NCC(C)CC1C

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 3/20 0.33
NOS1 P29475 3/20 0.33
NOS2 P35228 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7625495 0.80 NOS3 (0.39) NOS3NOS1NOS2
SCHEMBL7940036 0.69
SCHEMBL18971597 0.67
SCHEMBL7624140 0.67 NOS3 (0.37) NOS3NOS1NOS2
SCHEMBL7618095 0.66 NOS3 (0.34) NOS3NOS1NOS2
SCHEMBL7625212 0.62
SCHEMBL7626616 0.59
SCHEMBL24092766 0.57 NOS3 (0.31) NOS3NOS1NOS2
SCHEMBL10070411 0.53 NOS3 (0.32) NOS3NOS1NOS2
SCHEMBL23913880 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629322-A TREATMENT OF NEURODEGENERATIVE DISORDERS, DISORDERS OF GASTROINTESTINAL MOTILITY AND INFLAMMATION MERCK & CO., INC. (US) 1997-05-13 US disclosed
WO-1996014844-A1 CYCLIC AMIDINE ANALOGS AS INHIBITORS OF NITRIC OXIDE SYNTHASE MERCK & CO., INC. (US) 1996-05-23 WO disclosed